Sponsor Pipeline

Alkermes Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
7
Recruiting
6
Phase 3
3
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-08 NCT07502443
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Trial sites expanded: 19 -> 28 locations
2026-08-08 NCT06767683
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Trial sites expanded: 46 -> 49 locations
2026-08-08 NCT07455383
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Trial sites expanded: 22 -> 29 locations
2026-08-08 NCT07540897
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With…
Trial sites expanded: 10 -> 14 locations
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-10 NCT07755410 A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult… Phase 2 Recruiting
2026-08-04 NCT07744113 An Expanded Access Program (EAP) for OLZ/SAM in Pediatric Participants With Schizophrenia… Available
Active Trials by Phase
Phase 3
5
Phase 2/3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07455383 A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 Narcolepsy Type 1 Recruiting
NCT07502443 A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 Narcolepsy Type 2 Recruiting
NCT07540897 A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With… Narcolepsy Type 1 Recruiting
NCT05303064 Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects… Schizophrenia Recruiting
NCT04987229 Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects Bipolar I Disorder Enrolling by Invitation
Phase 2/3
NCT06767683 A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia Narcolepsy Type 1 Recruiting
Phase 2
NCT06843590 A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic… Idiopathic Hypersomnia Recruiting
NCT07755410 A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult… Attention Deficit Disorder With Hyperactivity (ADHD) Recruiting
Disease Areas
Get alerts when Alkermes's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free